Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-21-021122

CFO and Treasurer sold 50,000 shares at an average $61.89 ($3,094,563)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Krognes Steve E. CFO and Treasurer 2021-03-15 Sale −13,258 $61.16 $810,912 886,742 I
Krognes Steve E. CFO and Treasurer 2021-03-15 Sale −32,326 $62.04 $2,005,602 854,416 I
Krognes Steve E. CFO and Treasurer 2021-03-15 Sale −3,258 $62.71 $204,319 851,158 I
Krognes Steve E. CFO and Treasurer 2021-03-15 Sale −1,158 $63.67 $73,730 850,000 I
Open-market sales · 50,000 sh · avg $61.89 · $3,094,563
Loading xslF345X03/doc4.xml…